Tech Company Financing Transactions
Synspira Funding Round
Synspira, based in Boston, secured $8 million from private investors.
Transaction Overview
Company Name
Announced On
6/30/2017
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
It has secured $8 million in funding from a private investor that will be used to advance a Phase 1 first-in-humans safety study of SNSP113 and has appointed a founding Board of Directors.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Boston, MA 02113
USA
Boston, MA 02113
USA
Phone
Website
Email Address
Overview
Synspira is developing a new class of inhalable glycopolymer-based therapeutics that disrupt mucus accumulation and biofilm invasion, which are key drivers of pulmonary diseases including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and pneumonia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shenda Baker
Chief Financial Officer
Kim Snyder
Chief Medical Officer
Gregory Fiore
VP - Manufacturing
Christopher Ryan
Browse more venture capital transactions:
Prev: 6/30/2017: Indi Molecular venture capital transaction
Next: 6/30/2017: Lynq venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs